News

Enzo Biochem Confirms Data Breach Leaked 600k Social Security Numbers and the Confidential Test Results of Nearly 2.5 Million Patients

by

MARLTON, N.J., June 2, 2023 /PRNewswire/ — Approximately 2.5 million people across the United States are being notified that their protected health information and Social Security numbers were compromised when hackers breached the computer system of Enzo Biochem, Inc. earlier this year. The data breach lawyers at Console & Associates, P.C. are investigating claims on … Read more

PatientRightsAdvocate.org Applauds Gov. Polis Signing Bipartisan Hospital Price Transparency Bill into Law

by

New law “a triumph for Colorado patients over secrecy and special interests” WASHINGTON, June 2, 2023 /PRNewswire/ — PatientRightsAdvocate.org (PRA) celebrated today’s signing of Senate Bill 252 by Colorado Governor Jared Polis at a public ceremony in Denver. The bipartisan legislation requires Colorado hospitals to comply with federal price transparency rules by posting all of their prices … Read more

Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference

by

SECAUCUS, N.J., June 2, 2023 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Global Healthcare Conference. Jim Davis, Chairman, CEO and President, will discuss recent market developments and trends as well as the company’s performance and strategy. The … Read more

CURE HOSTS “AI FOR GOOD” SUPER SESSION TO MAKE SENSE OF BIG DATA AND HIGH TECH AT 2023 BIO INTERNATIONAL CONVENTION ON JUNE 5

by

Cure CEO Seema Kumar to Announce BioGENEius Award Winner at BIO Opening Plenary and participate in Women In Bio Plenary June 5 Cure to Showcase Cure Innovation Labs, CureXChange Collaboration Residency and Cure Studio on the Road at BIO Exhibit NEW YORK, June 2, 2023 /PRNewswire/ — Cure®, a healthcare innovation campus in New York City, … Read more

IVBH Presents Groundbreaking Data for Early Lung Cancer Detection at the ASCO® 2023 Annual Meeting

by

IVBH’s novel RNA approach to early detection demonstrates strong sensitivity and specificity for early lung cancer detection, in a large, predominantly early-stage, independent validation cohort NEWPORT BEACH, Calif., June 2, 2023 /PRNewswire/ — IVBH, a leader in liquid biopsy technology, specializing in noninvasive early detection, will unveil groundbreaking data from an independent validation study of the … Read more

Dragonfly Therapeutics presentará los resultados de fase 1 de la monoterapia con DF1001

by

-Dragonfly Therapeutics presentará los resultados de fase 1 de la monoterapia con DF1001 en la reunión anual ASCO 2023 Una presentación oral titulada “Estudio de fase 1/2 de DF1001, un TriNKET® inmunomodulador dirigido contra HER2, en pacientes con tumores sólidos avanzados: Fase 1 DF1001 Resultados del escalado de dosis en monoterapia” será ofrecida por Howard … Read more

Final Days to Register: Europe Point-of-Care, Biosensors and Rapid Diagnostics Conference 2023 – From Novel Technologies to Regulatory Approval (Rotterdam, Netherlands

by

DUBLIN, June 2, 2023 /PRNewswire/ — The “Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023” training has been added to  ResearchAndMarkets.com’s offering. This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. The Point-of-Care, Biosensors & Rapid Diagnostics Europe 2023 will be held on-site as a standard multi-track physical … Read more

Volpara Health Joins CancerX

by

Volpara is a founding member in the White House’s new national accelerator to boost innovation in the fight against cancer LYNNWOOD, Wash., June 2, 2023 /PRNewswire/ — Volpara Health Technologies Ltd. (ASX: VHT) proudly announces its founding membership in CancerX, a public-private partnership aimed at revolutionizing cancer innovation in the United States. As a global … Read more

Antibodies Pipeline is Still in the Expansion Phase as Global and China Drug Developers are Continuously Foraying into the Market

by

DUBLIN, June 2, 2023 /PRNewswire/ — The “China Cancer Antibodies Market Trends & Clinical Trials Insight 2023” report has been added to  ResearchAndMarkets.com’s offering. The current antibodies pipeline in China is still in the expansion phase as both domestic and international drug developers are continuously foraying into the market. Ever since the Chinese government revised its … Read more

$1.55M Raised for Plan A™ Male Birth Control Product, Seeking Clinical Trials in 2023

by

LOS ANGELES, June 2, 2023 /PRNewswire/ — After years in development by the Parsemus Foundation, NEXT Life Sciences, Inc. has announced its plans to bring a new contraceptive product to market through Plan A™ – a safe, effective, reversible birth control for men. “In developing Plan A™, NEXT has seen increasing demand for male contraception … Read more